Словения - словенский - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

swedish orphan biovitrum international ab - interferon alfa - raztopina za injiciranje v napolnjeni injekcijski brizgi - interferon alfa 3 miljon i.e. / 1 ml - interferon alfa, naravni

Словения - словенский - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

aop orphan pharmaceuticals ag - naltrekson - filmsko obložena tableta - naltrekson 45,22 mg / 1 tableta - naltrekson

Словения - словенский - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

aop orphan pharmaceuticals ag - naltrekson - filmsko obložena tableta - naltrekson 45,22 mg / 1 tableta - naltrekson

Европейский союз - словенский - EMA (European Medicines Agency)

swedish orphan biovitrum international ab - nitizinon - tyrosinemias - drugi zdravljene bolezni prebavil in presnove izdelki, - hereditary tyrosinemia type 1 (ht 1)orfadin is indicated for the treatment of adult and paediatric (in any age range) patients with confirmed diagnosis of hereditary tyrosinemia type 1 (ht 1) in combination with dietary restriction of tyrosine and phenylalanine. alkaptonuria (aku)orfadin is indicated for the treatment of adult patients with alkaptonuria (aku).

Европейский союз - словенский - EMA (European Medicines Agency)

swedish orphan biovitrum ab - loncastuximab tesirine - lymphoma, large b-cell, diffuse; lymphoma, b-cell - antineoplastična sredstva - zynlonta as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl), after two or more lines of systemic therapy.

Европейский союз - словенский - EMA (European Medicines Agency)

swedish orphan biovitrum ab (publ) - emapalumab - immune system diseases - gamifant is indicated for the treatment of paediatric patients aged under 18 years with primary haemophagocytic lymphohistiocytosis (hlh).

Европейский союз - словенский - EMA (European Medicines Agency)

swedish orphan biovitrum ab (publ) - eftrenonakog alfa - hemofilija b - vitamin k in druge hemostatics, faktorji strjevanja krvi - zdravljenje in profilaksa krvavitve pri bolnikih s hemofilijo b (prirojene pomanjkljivosti faktorja ix).

Европейский союз - словенский - EMA (European Medicines Agency)

swedish orphan biovitrum ab (publ) - efmoroctocog alfa - hemofilija a - antihemoragije - zdravljenje in profilaksa krvavitve pri bolnikih s hemofilijo a (prirojeno pomanjkanje faktorja viii). elocta se lahko uporablja za vse starostne skupine.

Европейский союз - словенский - EMA (European Medicines Agency)

swedish orphan biovitrum ab (publ) - anakinra - arthritis, rheumatoid; covid-19 virus infection - imunosupresivi - revmatoidni artritis (ra)kineret je navedeno pri odraslih za zdravljenje znakov in simptomov ra v kombinaciji z metotreksatom, z nezadosten odziv na sam metotreksat. covid-19kineret is indicated for the treatment of coronavirus disease 2019 (covid-19) in adult patients with pneumonia requiring supplemental oxygen (low- or high-flow oxygen) who are at risk of progressing to severe respiratory failure determined by plasma concentration of soluble urokinase plasminogen activator receptor (supar) ≥ 6 ng/ml. periodic fever syndromeskineret is indicated for the treatment of the following autoinflammatory periodic fever syndromes in adults, adolescents, children and infants aged 8 months and older with a body weight of 10 kg or above:cryopyrin-associated periodic syndromes (caps)kineret is indicated for the treatment of caps, including:neonatal-onset multisystem inflammatory disease (nomid) / chronic infantile neurological, cutaneous, articular syndrome (cinca)muckle-wells syndrome (mws)familial cold autoinflammatory syndrome (fcas)familial mediterranean fever (fmf)kineret is indicated for the treatment of familial mediterranean fever (fmf). kineret je treba v kombinaciji z colchicine, če je primerno. Še vedno je diseasekineret je navedeno pri odraslih, mladostnikov, otrok in dojenčkov, starih od 8 mesecev in več s telesno maso 10 kg ali več, za zdravljenje še vedno je bolezen, vključno s sistemsko mladoletnike idiopatsko artritis (sjia) in odrasle-nastop še vedno je bolezen (aosd), z aktivnim sistemske značilnosti zmerno do visoko aktivnosti bolezni, ali pri bolnikih s nadaljevanje aktivnosti bolezni po zdravljenju z nesteroidna protivnetna zdravila (nesteroidnih protivnetnih zdravil) ali glucocorticoids. kineret can be given as monotherapy or in combination with other anti-inflammatory drugs and disease-modifying antirheumatic drugs (dmards).

Европейский союз - словенский - EMA (European Medicines Agency)

swedish orphan biovitrum ab - kolagenaza clostridium histolyticum - dupuytren pogodbe - druga zdravila za motnje mišično-skeletnega sistema - , the treatment of dupuytren’s contracture in adult patients with a palpable cord. obravnava odraslih moških z peyronijeve bolezni z otipljiv plaketo in ukrivljenosti deformacijo vsaj 30 stopinj na začetku terapije.